Lehre & Forschung

A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor Xa Inhibitor (ANNEXA)

Status: current

Capsaicin for post-stroke dysphagia (CADYS). The aim of this multicenter, randomizes, double-blind study is to examine the effect of Capsaicin treatment in the setting of (sub-)acute stroke, compared to placebo.

Status: planned

The 2nd European Carotid Surgery Trial.

Status: ongoing, recruitment finished

Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): an international, multicentre, randomised-controlled, two-arm, assessor-blinded Trial.

Status: ongoing, recruiting

Early Sleep Apnea Treatment in Stroke: A Randomized, Rater-Blinded, Clinical Trial of Adaptive Servo-Ventilation.

Status: recruiting

Enhancement of Stroke Rehabilitation with Levodopa (ESTREL): a randomized placebo-controlled Trial.

Status: planned

This study focuses on the relationship between obesity and stroke, which are both characterized by increasing incidence and prevalence with epidemic proportions worldwide and tremendous socio-economic consequences.

Status: current

The present trial is addressing the question if a biologically distinct subgroup of ischemic stroke patients without known atrial fibrillation at admission, selected by a cut-off level of MRproANP concentration, which represents a underlying increased risk of cardiac thrombogenicity, benefits from direct oral anticoagulation (DOAC) versus antiplatelets as preventive treatment.

MidregiOnal proatrial natriuretic peptide to guide Secondary Stroke prevention: The MOSES Study

Status: current

Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – noncardioembolic Stroke study, PACIFIC STROKE

Status: current

Schweizweite Datenbank zum akuten Schlaganfall.

Status: current